International Journal on Magnetic Particle Imaging IJMPI
Vol. 12 No. 1 Suppl 1 (2026): Int J Mag Part Imag
https://doi.org/10.18416/IJMPI.2026.2603022

Proceedings Articles, ID 1013

Magnetosomes: The future of theranostics?

Main Article Content

Oliver Buchholz (Universitätsklinik Freiburg), Marina Dziuba (Department of Microbiology, University of Bayreuth, Bayreuth, Germany), Simon Markert (Department of Microbiology, University of Bayreuth, Bayreuth, Germany), Dirk Schüler (Department of Microbiology, University of Bayreuth, Bayreuth, Germany), Ulrich G. Hofmann (Division of Medical Physics, Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany), Serhat Ilbey (Bruker BioSpin GmbH & Co. KG, Ettlingen, Germany), Jochen Franke (Bruker BioSpin GmbH & Co. KG, Ettlingen, Germany), Frank Mickoleit (Department of Microbiology, University of Bayreuth, Bayreuth, Germany)

Copyright (c) 2026 Oliver Buchholz, Marina Dziuba, Simon Markert, Dirk Schüler, Ulrich G. Hofmann, Serhat Ilbey, Jochen Franke, Frank Mickoleit

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Magnetic nanoparticles serve as essential tracers in biomedical applications, including diagnostics such as magnetic particle imaging (MPI) and therapies like magnetic fluid hyperthermia (MFH). However, meeting the physicochemical requirements of both applications within a single nanoparticle system remains challenging. Magnetosomes, a novel class of magnetic iron oxide nanoparticles biosynthesized by bacteria, offer a promising solution, as their magnetic properties can be tuned through genetic engineering. Here, magnetosomes are investigated for dual functionality as MPI tracers and MFH heat mediators, highlighting their potential as a theranostic platform.

Article Details